REGN vs VRTX: Which Stock is Better?
Side-by-side comparison of Regeneron Pharmaceuticals Inc and Vertex Pharmaceuticals Inc in 2026
REGN
Regeneron Pharmaceuticals Inc
$660.70
VRTX
Vertex Pharmaceuticals Inc
$481.65
Key Metrics Comparison
| Metric | REGN | VRTX | Winner |
|---|---|---|---|
| Market Cap | $59.10B | $106.87B | VRTX |
| P/E Ratio | 13.91 | 29.67 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze REGN
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is REGN or VRTX a better investment?
Comparing REGN and VRTX: Regeneron Pharmaceuticals Inc has a market cap of $59.10B while Vertex Pharmaceuticals Inc has $106.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between REGN and VRTX?
REGN (Regeneron Pharmaceuticals Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: REGN or VRTX?
Based on P/E ratios, REGN trades at a lower multiple (13.9x vs 29.7x).
Which is growing faster: REGN or VRTX?
Both REGN and VRTX show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: REGN or VRTX?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: REGN or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $106.87B compared to $59.10B for REGN.
Should I buy REGN or VRTX in 2026?
Both REGN and VRTX have investment merit. REGN trades at $660.70 while VRTX trades at $481.65. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between REGN and VRTX stock?
Key differences: Market Cap ($59.10B vs $106.87B), P/E Ratio (13.9x vs 29.7x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy REGN or VRTX in 2026?
The choice between REGN and VRTX depends on your investment goals. VRTX shows higher revenue growth (0.0%). VRTX has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between REGN and VRTX?
REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B, while VRTX (Vertex Pharmaceuticals Inc) has a market cap of $106.87B. VRTX is the larger company by market value.